Loading...
XSHE
000705
Market cap465mUSD
Sep 30, Last price  
9.92CNY
Name

Zhejiang Zhenyuan Share Co Ltd

Chart & Performance

D1W1MN
P/E
95.44
P/S
0.89
EPS
0.10
Div Yield, %
0.60%
Shrs. gr., 5y
0.78%
Rev. gr., 5y
2.90%
Revenues
3.74b
-8.91%
880,572,204908,433,631954,582,9101,112,773,6041,276,037,7011,503,278,7151,719,497,2441,812,211,1152,018,147,6452,081,233,1402,163,505,5482,440,003,8922,577,916,0462,858,058,6263,243,149,4113,439,840,4403,612,045,2554,145,479,3054,106,371,5953,740,688,470
Net income
35m
-57.46%
5,295,7567,763,1597,729,82412,244,51817,791,33021,072,40531,536,13347,672,70264,438,12439,078,85836,225,61645,275,57761,082,49070,884,105211,570,67889,392,93477,295,07077,909,26581,642,56634,729,260
CFO
76m
-16.21%
28,940,50748,743,35248,384,36331,792,46026,217,24149,076,3800126,488,86217,390,49781,407,56756,744,630115,993,13351,721,83225,488,980118,359,124154,814,64075,165,175090,819,92876,095,427
Dividend
Jun 07, 20240.06 CNY/sh

Profile

Zhejiang Zhenyuan Share Co., Ltd. operates as a pharmaceutical company in China and internationally. It offers Chinese patent medicines, Chinese medicinal materials, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, anesthetics, psychotropic drugs, medical devices, chemical reagents, etc. The company offers its products under the Zhenyuan and Zhenyuantang brands. It serves pharmaceutical commerce and health service industries. The company was founded in 1752 and is based in Shaoxing, China.
IPO date
Apr 10, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,740,688
-8.91%
4,106,372
-0.94%
4,145,479
14.77%
Cost of revenue
3,352,620
3,998,302
3,906,533
Unusual Expense (Income)
NOPBT
388,069
108,069
238,946
NOPBT Margin
10.37%
2.63%
5.76%
Operating Taxes
17,360
25,236
20,644
Tax Rate
4.47%
23.35%
8.64%
NOPAT
370,709
82,833
218,302
Net income
34,729
-57.46%
81,643
4.79%
77,909
0.79%
Dividends
(23,905)
(20,047)
(20,505)
Dividend yield
0.87%
0.55%
0.77%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
249,193
28,083
Long-term debt
200,887
109,922
106,162
Deferred revenue
72,044
75,241
79,139
Other long-term liabilities
1
Net debt
(248,997)
(532,694)
(703,427)
Cash flow
Cash from operating activities
76,095
90,820
CAPEX
(331,385)
(194,056)
Cash from investing activities
(320,481)
1,139
109,310
Cash from financing activities
321,573
(66,227)
FCF
142,469
(76,380)
45,591
Balance
Cash
549,427
458,889
453,484
Long term investments
149,650
183,727
384,188
Excess cash
512,043
437,297
630,398
Stockholders' equity
1,278,359
1,294,424
1,415,597
Invested Capital
1,936,103
1,691,690
1,445,377
ROIC
20.44%
5.28%
15.43%
ROCE
15.69%
5.00%
11.21%
EV
Common stock shares outstanding
347,293
334,123
334,123
Price
7.91
-27.36%
10.89
37.33%
7.93
-10.70%
Market cap
2,747,085
-24.50%
3,638,603
37.33%
2,649,598
-10.70%
EV
2,499,250
3,128,763
1,969,628
EBITDA
486,069
208,708
331,221
EV/EBITDA
5.14
14.99
5.95
Interest
6,674
3,331
4,100
Interest/NOPBT
1.72%
3.08%
1.72%